Compound 1652
Identifiers
- Canonical SMILES:
COc1cc(CN[C@H](C)c2ccccc2)cc(Br)c1OCc1ccccc1Cl
- IUPAC name:
({3-bromo-4-[(2-chlorophenyl)methoxy]-5-methoxyphenyl}methyl)(1-phenylethyl)amine
- InChi:
InChI=1S/C23H23BrClNO2/c1-16(18-8-4-3-5-9-18)26-14-17-12-20(24)23(22(13-17)27-2)28-15-19-10-6-7-11-21(19)25/h3-13,16,26H,14-15H2,1-2H3/t16-/m1/s1
- InChiKey:
GBNFXGVUSNPSHS-MRXNPFEDSA-N
External links
![]() 1814661 |
![]() N |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
NRP / VEGF | 5.03 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 459.06 g/mol | |||
HBA | 3 | |||
HBD | 1 | |||
HBA + HBD | 4 | |||
AlogP | 6.45 | |||
TPSA | 30.49 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4783 | Priralfinamide | DB06649 | |
0.4783 | Safinamide | DB06654 | |
0.4702 | [3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid | DB02106 | |
0.4682 | Pinaverium | DB09090 | |
0.4518 | Raxatrigine | DB11706 | |
0.4495 | Dibrompropamidine | DB13548 | |
0.4483 | Itopride | DB04924 | |
0.4444 | N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide | DB07738 | |
0.4414 | Trimetazidine | DB09069 | |
0.4375 | Nisoxetine | DB09186 | |
0.4365 | N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE | DB08610 | |
0.4333 | Trimethobenzamide | DB00662 | |
0.4299 | Etamivan | DB08989 | |
0.4274 | Lomerizine | DB14065 | |
0.4222 | Fipexide | DB13790 |